Status:
UNKNOWN
Development and Needs Assessment and Efficiency of Smart Communication System for Patients With ALS (Part 2)
Lead Sponsor:
Taipei Veterans General Hospital, Taiwan
Conditions:
Amyotrophic Lateral Sclerosis
Eligibility:
All Genders
20+ years
Brief Summary
The research is aimed to asses the validity of the communication system improving the quality of life and the degree of sanctification of clinical patients and their caregiver.
Eligibility Criteria
Inclusion
- Escorial revised criteria (Brooks et al., 2000),The diagnosis of ALS requires:
- (A) the presence of:
- (A:1) evidence of lower motor neuron (LMN) degeneration by clinical, electrophysiological or neuropathologic examination (A:2) evidence of upper motor neuron (UMN) degeneration by clinical examination, and
- (A:3) progressive spread of symptoms or signs within a region or to other regions, as determined by history or examination, together with: (B) the absence of (B:1) electrophysiological or pathological evidence of other disease processes that might explain the signs of LMN and/or UMN degeneration, and (B:2) neuroimaging evidence of other disease processes that might explain the observed clinical and electrophysiological signs.
- If they were Taiwanese and used traditional Chinese(Mandarin).
- If they were older than age 20 years.
Exclusion
- If they had been diagnosed with frontotemporal dementia, severe depression, or schizophrenia.
- If they cannot see the communication board after correction.
- If they cannot complete the questionnaire with researchers or family members help.
Key Trial Info
Start Date :
March 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2020
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03806634
Start Date
March 1 2019
End Date
September 1 2020
Last Update
January 16 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Taipei Veterans General Hospital
Taipei, TW, Taiwan, 11217